Correspondence 0001493152-24-035497 from Xtant Medical Holdings, Inc. (XTNT)
Xtant Medical Holdings, Inc.
Date: Sept. 9, 2024 · CIK: 0001453593 · Accession: 0001493152-24-035497
AI Filing Summary & Sentiment
File numbers found in text: 333-281910
Show Raw Text
CORRESP
1
filename1.htm
664
Cruiser Lane
Belgrade,
Montana 59714
(406)
388-0480
September
9, 2024
VIA
EDGAR
United
States Securities and Exchange Commission
Division
of Corporation Finance
Office
of Life Sciences
100
F Street, NE
Washington,
DC 20549
Attention:
Alan Campbell
Re:
Xtant Medical Holdings, Inc.
Registration Statement
on Form S-3
Filed September 3, 2024
File No. 333-281910
Request for Acceleration
Ladies
and Gentlemen:
Pursuant
to Rule 461 of the Securities Act of 1933, as amended, Xtant Medical Holdings, Inc. (the “Company”) hereby respectfully requests
that the effective date of the above-referenced registration statement be accelerated so that it will be declared effective at 5:00 p.m.,
Eastern Time, on September 11, 2024, or as soon thereafter as is practicable.
The
Company requests that it be notified of such effectiveness by a telephone call to Emily Humbert of Fox Rothschild LLP at (612) 607-7076.
Thank
you for your assistance in this matter. Should you have any questions, please call Ms. Humbert.
Very truly yours,
XTANT MEDICAL HOLDINGS, INC.
/s/ Sean E. Browne
Sean E. Browne
President and Chief Executive Officer
cc:
Amy
E. Culbert, Esq.
Emily
Humbert, Esq.